Impaired sympathoadrenal axis function contributes to enhanced insulin secretion in prediabetic obese rats

Experimental Diabetes Research

Volumn 2011, Issue , 2011, Pages

  Andreazzi, Ana Eliza ^a   Grassiolli, Sabrina ^b   Marangon, Paula Beatriz ^b   Martins, Adriana Gallego ^b   De Oliveira, Júlio Cézar ^b   Torrezan, Rosana ^b   Gravena, Clarice ^b   Garcia, Ral Marcel González ^a   De Freitas Mathias, Paulo Cezar ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CARBACHOL; CATECHOLAMINE; GLUTAMATE SODIUM; POTASSIUM; INSULIN;

ADRENAL MEDULLA; ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; INSULIN RELEASE; MALE; NEWBORN; NONHUMAN; OBESITY; PANCREAS ISLET; PRIORITY JOURNAL; RAT; SUPERIOR CERVICAL GANGLION; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; PATHOPHYSIOLOGY; SECRETION; WISTAR RAT;

ADRENAL MEDULLA; ANIMALS; BLOOD GLUCOSE; CAFFEINE; CARBACHOL; CATECHOLAMINES; GLUCOSE TOLERANCE TEST; INSULIN; MALE; OBESITY; PREDIABETIC STATE; RATS; RATS, WISTAR; SODIUM GLUTAMATE; SYMPATHETIC NERVOUS SYSTEM;

EID: 80053525701     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2011/947917     Document Type: Article

References (70)

1. Coll T., Rodrguez-Calvo R., Barroso E., Serrano L., Eyre E., Palomer X., Vzquez-Carrera M., Peroxisome proliferator-activated receptor (PPAR) / : a new potential therapeutic target for the treatment of metabolic syndrome Current Molecular Pharmacology 2009 2 1 46 55
2. De Flines J., Scheen A. J., Management of metabolic syndrome and associated cardiovascular risk factors Acta gastro-enterologica Belgica 2010 73 2 261 266
3. Vernochet C., Peres S. B., Farmer S. R., Mechanisms of obesity and related pathologies: transcriptional control of adipose tissue development FEBS Journal 2009 276 20 5729 5737
4. Berthoud H. R., Morrison C., The brain, appetite, and obesity Annual Review of Psychology 2008 59 55 92
5. Williams G., Bing C., Cai X. J., Harrold J. A., King P. J., Liu X. H., The hypothalamus and the control of energy homeostasis: different circuits, different purposes Physiology and Behavior 2001 74 4-5 683 701 (Pubitemid 34076616)
6. Abizaid A., Horvath T. L., Brain circuits regulating energy homeostasis Regulatory Peptides 2008 149 13 3 10
7. Obici S., Minireview: molecular targets for obesity therapy in the brain Endocrinology 2009 150 6 2512 2517
8. Yoshimatsu H., Egawa M., Bray G. A., Sympathetic nerve activity after discrete hypothalamic injections of L-glutamate Brain Research 1993 601 1-2 121 128 (Pubitemid 23047673)
9. Gao Q., Horvath T. L., Neuronal control of energy homeostasis FEBS Letters 2008 582 1 132 141 (Pubitemid 50014150)
10. Davy K. P., Orr J. S., Sympathetic nervous system behavior in human obesity Neuroscience and Biobehavioral Reviews 2009 33 2 116 124
11. Teff K. L., Visceral nerves: vagal and sympathetic innervation Journal of Parenteral and Enteral Nutrition 2008 32 5 569 571
12. Ravussin E., Tataranni P. A., The role of altered sympathetic nervous system activity in the pathogenesis of obesity Proceedings of the Nutrition Society 1996 55 3 793 802 (Pubitemid 126773143)
13. Tentolouris N., Argyrakopoulou G., Katsilambros N., Perturbed autonomic nervous system function in metabolic syndrome NeuroMolecular Medicine 2008 10 3 169 178
14. Bray G. A., York D. A., Fisler J. S., Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system Vitamins and Hormones 1989 45 1 125
15. Bray G. A., Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis Journal of Nutrition 1991 121 8 1146 1162
16. Young J. B., Developmental origins of obesity: a sympathoadrenal perspective International Journal of Obesity 2006 30 4 S41 S49
17. Sala F., Nistri A., Criado M., Nicotinic acetylcholine receptors of adrenal chromaffin cells Acta Physiologica 2008 192 2 203 212 (Pubitemid 351160989)
18. Silva J. E., Bianco S. D. C., Thyroid-adrenergic interactions: physiological and clinical implications Thyroid 2008 18 2 157 165 (Pubitemid 351271529)
19. Schenk S., Saberi M., Olefsky J. M., Insulin sensitivity: modulation by nutrients and inflammation Journal of Clinical Investigation 2008 118 9 2992 3002
20. Lee M., Korner J., Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans Pituitary 2009 12 2 87 95
21. Scomparin D. X., Grassiolli S., Maral A. C., Gravena C., Andreazzi A. E., Mathias P. C. F., Swim training applied at early age is critical to adrenal medulla catecholamine content and to attenuate monosodium l-glutamate-obesity onset in mice Life Sciences 2006 79 22 2151 2156 (Pubitemid 44573279)
22. Bernardis L. L., Patterson B. D., Correlation between Lee index and carcass fat content in weanling and adult female rats with hypothalamic lesions Journal of Endocrinology 1968 40 4 527 528
23. Leon-Quinto T., Magnan C., Portha B., Altered activity of the autonomous nervous system as a determinant of the impaired -cell secretory response after protein-energy restriction in the rat Endocrinology 1998 139 8 3382 3389 (Pubitemid 28512292)
24. Kelner K. L., Levine R. A., Morita K., Pollard H. B., A comparison of trihydroxyindole and HPLC/electrochemical methods for catecholamine measurement in adrenal chromaffin cells Neurochemistry International 1985 7 2 373 378 (Pubitemid 15116220)
25. Martins A. C. P., Souza K. L. A., Shio M. T., Mathias P. C. F., Lelkes P. I., Garcia R. M. G., Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity Life Sciences 2004 74 26 3211 3222 (Pubitemid 38501622)
26. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Analytical Biochemistry 1976 72 1-2 248 254
27. Krstulovic A. M., Investigations of catecholamine metabolism using high-performance liquid chromatography. Analytical methodology and clinical applications Journal of Chromatography 1982 229 1 1 34 (Pubitemid 12087123)
28. Scott A. M., Atwater I., Rojas E., A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans Diabetologia 1981 21 5 470 475 (Pubitemid 11027869)
29. Hermans M. P., Schmeer W., Henquin J. C., Modulation of the effect of acetylcholine on insulin release by the membrane potential on B cells Endocrinology 1987 120 5 1765 1773 (Pubitemid 17069203)
30. Grassiolli S., Bonfleur M. L., Scomparin D. X., De Freitas Mathias P. C., Pancreatic islets from hypothalamic obese rats maintain K+ATP channel-dependent but not -independent pathways on glucose-induced insulin release process Endocrine 2006 30 2 191 196 (Pubitemid 46340520)
31. Maral A. C., Grassiolli S., Da Rocha D. N., Puzzi M. A., Gravena C., Scomparin D. X., De Freitas Mathias P. C., The dual effect of isoproterenol on insulin release is suppressed in pancreatic islets from hypothalamic obese rats Endocrine 2006 29 3 445 449 (Pubitemid 44358834)
32. Sieg A., Su J., Muoz A., Buchenau M., Nakazaki M., Aguilar-Bryan L., Bryan J., Ullrich S., Epinephrine-induced hyperpolarization of islet cells without K ATP channels American Journal of Physiology 2004 286 3 E463 E471
33. Bunyan J., Murrell E. A., Shah P. P., The induction of obesity in rodents by means of monosodium glutamate British Journal of Nutrition 1976 35 1 25 39
34. Olney J. W., Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate Science 1969 164 3880 719 721
35. Dolnikoff M., Martn-Hidalgo A., Machado U. F., Lima F. B., Herrera E., Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats International Journal of Obesity 2001 25 3 426 433 (Pubitemid 32209820)
36. Balbo S., Grassiolli S., Ribeiro R., Bonfleur M., Gravena C., Brito M., Andreazzi A., Mathias P., Torrezan R., Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat Endocrine 2007 31 2 142 148 (Pubitemid 350195148)
37. Grassiolli S., Gravena C., de Freitas Mathias P. C., Muscarinic M2 receptor is active on pancreatic islets from hypothalamic obese rat European Journal of Pharmacology 2007 556 13 223 228 (Pubitemid 46074015)
38. Maiter D., Underwood L. E., Martin J. B., Koenig J. I., Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats Endocrinology 1991 128 2 1100 1106
39. Young J. B., Landsberg L., Diminished sympathetic nervous system activity in genetically obese (ob/ob) mouse The American journal of physiology 1983 245 2 E148 E154
40. Levin B. E., Reduced norepinephrine turnover in organs and brains of obesity-prone rats American Journal of Physiology 1995 268 2 R389 R394
41. Saad M. F., Alger S. A., Zurlo F., Young J. B., Bogardus C., Ravussin E., Ethnic differences in sympathetic nervous system-mediated energy expenditure American Journal of Physiology 1991 261 6 E789 E794
42. Davy K. P., Hall J. E., Obesity and hypertension: two epidemics or one? American Journal of Physiology 2004 286 5 R803 R813
43. Yoshida T., Yoshioka K., Hiraoka N., Kondo M., Effect of nicotine on norepinephrine turnover and thermogenesis in brown adipose tissue and metabolic rate in MSG obese mice Journal of Nutritional Science and Vitaminology 1990 36 2 123 130 (Pubitemid 20327503)
44. de Andrade I. S., Gonzalez J. C. G., Hirata A. E., Carneiro G., Amado D., Cavalheiro E. A., Dolnikoff M. S., Central but not peripheral glucoprivation is impaired in monosodium glutamate-treated rats Neuroscience Letters 2006 398 1-2 6 11
45. Andreazzi A. E., Scomparin D. X., Mesquita F. P., Balbo S. L., Gravena C., De Oliveira J. C., Rinaldi W., Garcia R. M. G., Grassiolli S., Mathias P. C. F., Swimming exercise at weaning improves glycemic control and inhibits the onset of monosodium L-glutamate-obesity in mice Journal of Endocrinology 2009 201 3 351 359
46. Young J. B., MacDonald I. A., Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980 International Journal of Obesity 1992 16 12 959 967 (Pubitemid 23010019)
47. Astrup A., The sympathetic nervous system as a target for intervention in obesity International Journal of Obesity 1995 19 supplement 7 S24 S28
48. Young J. B., Programming of sympathoadrenal function Trends in Endocrinology and Metabolism 2002 13 9 381 385 (Pubitemid 36723590)
49. Jocken J. W. E., Blaak E. E., Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity Physiology and Behavior 2008 94 2 219 230 (Pubitemid 351615431)
50. Martins A. C. P., Borges H. E., Garcia R. M. G., Carniatto S. R., Mathias P. C. F., Monosodium L-glutamate-induced obesity impaired the adrenal medullae activity Neuroscience Research Communications 2001 28 1 49 58 (Pubitemid 32194793)
51. Yoshida T., Nishioka H., Nakamura Y., Reduced norepinephrine turnover in brown adipose tissue of pre-obese mice treated with monosodium-L-glutamate Life Sciences 1985 36 10 931 938 (Pubitemid 15080850)
52. Leigh F. S. M., Kaufman L. N., Young J. B., Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats International Journal of Obesity 1992 16 8 597 604
53. Kumer S. C., Vrana K. E., Intricate regulation of tyrosine hydroxylase activity and gene expression Journal of Neurochemistry 1996 67 2 443 462 (Pubitemid 26255637)
54. Daz-Flores L., Gutiérrez R., Varela H., Valladares F., Alvarez-Argelles H., Borges R., Histogenesis and morphofunctional characteristics of chromaffin cells Acta Physiologica 2008 192 2 145 163 (Pubitemid 351160995)
55. Albert K. A., Helmer-Matyjek E., Nairn A. C., Calcium/phospholipid- depending protein kinase (protein kinase C) phosphorylates and activates tyrosine hydroxylase Proceedings of the National Academy of Sciences of the United States of America 1984 81 24 7713 7717 (Pubitemid 15169131)
56. Akaike A., Sasa M., Tamura Y., Ujihara H., Takaori S., Effects of protein kinase C on the muscarinic excitation of rat adrenal chromaffin cells Japanese Journal of Pharmacology 1993 61 2 145 148 (Pubitemid 23090117)
57. Reaven G. M., The insulin resistance syndrome: definition and dietary approaches to treatment Annual Review of Nutrition 2005 25 391 406 (Pubitemid 41209007)
58. Campbell R. K., Fate of the beta-cell in the pathophysiology of type 2 diabetes Journal of the American Pharmacists Association 2009 49 S10 S15
59. Kalra S. P., Kalra P. S., Neuroendocrine control of energy homeostasis: update on new insights Progress in brain research 2010 181 17 33
60. Hirata A. E., Andrade I. S., Vaskevicius P., Dolnikoff M. S., Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake Brazilian Journal of Medical and Biological Research 1997 30 5 671 674 (Pubitemid 127521185)
61. Macho L., Fickov M., Jeov D., Zrad S., Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats Physiological Research 2000 49 1 S79 S85
62. Thirone A. C. P., Carvalheira J. B. C., Hirata A. E., Velloso L. A., Saad M. J. A., Regulation of Cbl-associated protein/Cbl pathway in muscle and adipose tissues of two animal models of insulin resistance Endocrinology 2004 145 1 281 293 (Pubitemid 38094522)
63. Balbo S. L., Mathias P. C., Bonfleur M. L., Alves H. F., Siroti F. J., Gomes Monteiro O., Borges Ribeiro F., Da Silva Fernando Souza A. C. M., Vagotomy reduces obesity in MSG-treated rats Research Communications in Molecular Pathology and Pharmacology 2000 108 5-6 291 296 (Pubitemid 34563339)
64. Kim Y. W., Kim J. Y., Lee S. K., Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats Journal of Korean Medical Science 1999 14 5 539 545
65. Jeanrenaud B., Neuro-endocrine disorders in obesity International Journal for Vitamin and Nutrition Research 1986 29 41 48
66. Mitrani P., Srinivasan M., Dodds C., Patel M. S., Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model American Journal of Physiology 2007 292 5 E1364 E1377
67. Nolan C. J., Leahy J. L., Delghingaro-Augusto V., Moibi J., Soni K., Peyot M. L., Fortier M., Guay C., Lamontagne J., Barbeau A., Przybytkowski E., Joly E., Masiello P., Wang S., Mitchell G. A., Prentki M., Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling Diabetologia 2006 49 9 2120 2130 (Pubitemid 44168480)
68. Cawthorn E. G., Chan C. B., Effect of pertussis toxin on islet insulin secretion in obese (fa/fa) Zucker rats Molecular and Cellular Endocrinology 1991 75 3 197 204
69. Tassava T. M., Okuda T., Romsos D. R., Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters American Journal of Physiology 1992 262 3 E338 E343
70. Cruciani-Guglielmacci C., Vincent-Lamon M., Rouch C., Orosco M., Ktorza A., Magnan C., Early changes in insulin secretion and action induced by high-fat diet are related to a decreased sympathetic tone American Journal of Physiology 2005 288 1 E148 E154